 | Arcturus CEO on How Messenger RNA Vaccines Work
www.thestreet.com - May 25 at 2:51 PM |
| Arcturus CEO on Possibility of COVID-19 Vaccine By End of 2020
www.thestreet.com - May 25 at 9:49 AM |
| Arcturus CEO on Vaccine Candidate, Moderna's Vaccine
www.thestreet.com - May 22 at 5:25 PM |
 | Ultragenyx Announces Exercise of Option to Purchase Additional Stock of Arcturus Therapeutics
finance.yahoo.com - May 21 at 11:22 AM |
 | Thinking about trading stocks and options in Arcturus Therapeutics, Novavax, Spirit Airlines, Aquestive Therapeutics, or Penn National Gaming?
www.prnewswire.com - May 18 at 1:21 PM |
 | Arcturus Therapeutics Ltd (NASDAQ:ARCT) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - May 14 at 5:53 PM |
| Arcturus Therapeutics Sees Unusually High Options Volume (NASDAQ:ARCT)
www.americanbankingnews.com - May 13 at 6:46 AM |
| Investors Buy High Volume of Arcturus Therapeutics Call Options (NASDAQ:ARCT)
www.americanbankingnews.com - May 12 at 7:28 PM |
| Is Arcturus Therapeutics (ARCT) Stock a Solid Choice Right Now?
finance.yahoo.com - May 12 at 6:34 PM |
| Arcturus Therapeutics Ltd (NASDAQ:ARCT) Sees Large Increase in Short Interest
www.americanbankingnews.com - May 11 at 8:10 PM |
|
 | Arcturus Therapeutics' (ARCT) CEO Joseph Payne on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 11 at 9:08 AM |
| Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 10 at 7:21 AM |
| Arcturus Therapeutics (NASDAQ:ARCT) Posts Earnings Results, Misses Estimates By $0.08 EPS
www.americanbankingnews.com - May 10 at 12:50 AM |
 | The Global RNA Interference Technology Market is...
www.benzinga.com - May 8 at 11:17 PM |
 | BRIEF-Arcturus Therapeutics Files For Mixed Shelf Of Upto $200 Million
www.reuters.com - May 8 at 11:17 PM |
| Arcturus up on new preclinical data on COVID-19 vaccine
seekingalpha.com - May 8 at 6:16 PM |
| Arcturus Reports Additional Supportive Preclinical Data for its COVID-19 Vaccine Candidate (LUNAR-COV19)
finance.yahoo.com - May 8 at 6:16 PM |
| Arcturus Therapeutics EPS misses by $0.08, misses on revenue
seekingalpha.com - May 7 at 6:06 PM |
| Arcturus Therapeutics Announces First Quarter 2020 Financial Results and Provides a Corporate Update
finance.yahoo.com - May 7 at 6:06 PM |
| $7.52 Million in Sales Expected for Arcturus Therapeutics Ltd (NASDAQ:ARCT) This Quarter
www.americanbankingnews.com - May 6 at 2:44 AM |
| Arcturus Therapeutics (ARCT) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - May 5 at 7:09 PM |
 | As Arcturus Therapeutics Holdings Inc hits a yearly high, is it too late to buy shares?
uk.finance.yahoo.com - May 5 at 7:51 AM |
| BRIEF-Arcturus Therapeutics, Catalent Announce Partnership To Manufacture Covid-19 Vaccine
www.reuters.com - May 4 at 4:10 PM |
| Arcturus Therapeutics to Report First Quarter 2020 Financial Results and Provide a Corporate Update on May 7, 2020
finance.yahoo.com - May 4 at 4:10 PM |
| Zacks: Brokerages Anticipate Arcturus Therapeutics Ltd (NASDAQ:ARCT) to Announce -$0.49 Earnings Per Share
www.americanbankingnews.com - May 4 at 3:57 PM |
| Arcturus Therapeutics (NASDAQ:ARCT) Rating Reiterated by HC Wainwright
www.americanbankingnews.com - May 4 at 11:59 AM |
| Arcturus Therapeutics and Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine
finance.yahoo.com - May 4 at 8:51 AM |
| CORRECTED-BRIEF-Arcturus Reports Positive Preclinical Data For Covid-19 Vaccine Candidate (April 27)
www.reuters.com - April 28 at 1:46 PM |
 | Arcturus Spikes 24% on Positive Preclinical Data For COVID-19 Vaccine Candidate
www.nasdaq.com - April 27 at 10:45 PM |
 | Familial Amyloid Polyneuropathy Therapeutics Market | Size, Growth, Trends, Regional Forecast And Industry Trends Analysis 2020-2026
www.marketwatch.com - April 27 at 12:44 PM |
| BRIEF-Arcturus Reports Positive Preclinical Data For Covid-19 Vaccine Candidate
www.reuters.com - April 27 at 7:43 AM |
| Arcturus Reports Positive Preclinical Data for its COVID-19 Vaccine Candidate
finance.yahoo.com - April 27 at 7:43 AM |
| Arcturus Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - April 21 at 8:16 AM |
| Arcturus prices stock offering at $17
seekingalpha.com - April 16 at 12:07 PM |
| Arcturus Therapeutics Announces Pricing of $70.0 Million Public Offering of Common Stock
finance.yahoo.com - April 16 at 12:07 PM |
| Arcturus Therapeutics Announces Proposed Public Offering of Common Stock
finance.yahoo.com - April 15 at 9:01 PM |
| BRIEF-Arcturus Announces Approval Of Clinical Trial Application For ARCT-810
www.reuters.com - April 13 at 9:04 AM |
| Arcturus Therapeutics Announces Allowance of IND & Approval of Clinical Trial Application (CTA) for ARCT-810, a First-in-Class Investigational mRNA Medicine to Treat Ornithine Transcarbamylase Deficiency
finance.yahoo.com - April 13 at 9:04 AM |
| Arcturus Therapeutics Announces Clinical Trial Timeline for its COVID-19 Vaccine
finance.yahoo.com - April 9 at 8:54 AM |
| Arcturus bullish on Duke system in Covid-19 vaccine development
seekingalpha.com - March 27 at 1:09 PM |
| Arcturus COVID-19 Vaccine to Benefit from Duke-NUS Genetic Correlation System
finance.yahoo.com - March 27 at 8:09 AM |
 | Singapore Scientists Study Genes to Fast-Track Coronavirus Vaccine
www.nytimes.com - March 24 at 9:34 AM |
 | Global Equities Tumble on Fears Governments Will Need More Stimulus to Battle Coronavirus Effects
www.barrons.com - March 18 at 8:23 AM |
| Arcturus Therapeutics Holdings Inc. Analysts Are Pretty Bullish On The Stock After Recent Results
finance.yahoo.com - March 14 at 12:39 PM |
| Arcturus Therapeutics (ARCT) Reports Q4 Loss, Lags Revenue Estimates
finance.yahoo.com - March 11 at 10:16 PM |
| Arcturus Therapeutics EPS misses by $0.25, misses on revenue
seekingalpha.com - March 11 at 5:16 PM |
| BRIEF-Arcturus Therapeutics Reports Fourth Quarter And Year End 2019 Financial Results
www.reuters.com - March 11 at 5:16 PM |
| Arcturus Therapeutics Holdings Inc to Host Earnings Call
finance.yahoo.com - March 11 at 5:16 PM |
| Arcturus Therapeutics Reports Fourth Quarter and Year End 2019 Financial Results
finance.yahoo.com - March 11 at 5:16 PM |
| Coronavirus Vaccine Makes This Stock a “Strong Buy”
finance.yahoo.com - March 6 at 12:17 PM |
